Pregnancy Clinical Trial
Official title:
Osteopathic Manipulative Medicine in Pregnancy: Physiologic and Clinical Effects
The purpose of this study is to determine to what extent and by what physiological mechanisms Osteopathic Manipulative Medicine (OMM) affects selected conditions related to pregnancy, labor and delivery.
The osteopathic philosophy of health is built on a model in which basic body functions are
coordinated and integrated by the musculoskeletal system. Osteopathic medical students are
taught to consider these aspects in assessing, diagnosing, and treating the individual
patient. As a treatment method that reflects the osteopathic philosophy, osteopathic
manipulative medicine (OMM) is a body-based modality in which the patient is evaluated and
treated as a whole to improve physiologic functioning and remove impediments to optimal
health and functioning.
During pregnancy, a woman's body is challenged by significant and extensive physiological and
biomechanical changes. Some physiological changes, such as increased fluid volume and
sympathetic tone, may lead to consequences such as edema, preterm labor, and
meconium-staining of the amniotic fluid. The biomechanical state of the woman's body is also
drastically affected; as the fetus grows and the uterus expands, the center of gravity shifts
forward, rotating the pelvis anteriorly and increasing the lordosis of the low back, and may
also affect the motion of the hips and legs. These postural changes also have consequences
such as low back pain, decreased functional status, and altered gait. Both these physiologic
and biomechanical consequences can have a significant long-term impact on the health of the
mother and child.
OMM is theorized to facilitate the body's adjustment to the physiological and biomechanical
demands of pregnancy and improve the outcomes of pregnancy, labor and delivery. Clinical case
studies report reduced back pain, shorter labor, and fewer incidences of peripartum
complications in patients who receive prenatal OMM. However, to date we have found no
published systematic investigations of the efficacy of OMM in managing the adverse effects
that pregnancy has on a woman's musculoskeletal system, nor have we found any published
systematic studies to prove the mechanisms of action of OMM in managing pain, edema, or gait
in pregnant patients.
Thus, the overall question that guides this proposal is: to what extent and by what
physiological mechanisms does Osteopathic Manipulative Medicine (OMM) affect selected
conditions related to pregnancy, labor and delivery? Based on the principles and theories of
OMM and the limited previous studies, the hypothesis of this study is that OMM improves
clinical outcomes including low back pain, functional status, incidence of meconium-stained
amniotic fluid, and complications of labor and delivery, and that the physiological changes
related to improved autonomic regulation, peripheral hemodynamic regulation, and
biomechanical changes related to gait are, in part, responsible for these clinical benefits.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |